Indication
Primary Immune Deficiency Disorders
2 clinical trials
3 products
Clinical trial
A Study Evaluating BPX-501 T Cells and AP1903 for Prevention of Graft Versus Host Disease (GVHD) After Haploidentical, Related, T Cell-Depleted Hematopoietic Cell Transplantation for Non-Malignant DiseasesStatus: Terminated, Estimated PCD: 2015-09-01
Product
BPX-501Product
BPX-501 and RimiducidClinical trial
Study of TCR Alpha Beta T-Cell and CD19 B-Cell Depletion for Hematopoietic Cell Transplantation From Haploidentical Donors in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in ChildrenStatus: Recruiting, Estimated PCD: 2024-06-01